Articaine
Orabloc, Septocaine (articaine) is a small molecule pharmaceutical. Articaine was first approved as Septocaine on 2000-04-03. It is used to treat pain in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Combinations
Orabloc, Septocaine (discontinued: Articaine epinephrine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| articadent | NDA authorized generic | 2024-03-01 |
| articaine | NDA authorized generic | 2024-03-06 |
| articaine hcl and epinephrine | NDA authorized generic | 2023-01-14 |
| articaine hydrochloride and epinephrine | NDA authorized generic | 2024-11-18 |
| articaine hydrochloride and epinephrine bitartrate | New Drug Application | 2010-08-23 |
| orabloc | New Drug Application | 2018-11-22 |
| septocaine | 2006-12-26 | |
| septocaine and epinephrine | New Drug Application | 2024-10-23 |
| ultacan ultacan forte | ANDA | 2017-07-20 |
| zorcaine | NDA authorized generic | 2024-03-06 |
Indications
FDA
EMA
Show 2 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
208 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Local anesthesia | D000772 | — | — | — | 1 | 6 | 8 | 18 | 32 |
| Pulpitis | D011671 | EFO_1001139 | K04.0 | 3 | 4 | 3 | 5 | 12 | 25 |
| Pain | D010146 | EFO_0003843 | R52 | 2 | 3 | 1 | 5 | 11 | 21 |
| Impacted tooth | D014095 | — | K01.1 | — | — | — | 4 | 11 | 15 |
| Postoperative pain | D010149 | — | G89.18 | 1 | 1 | — | 4 | 10 | 15 |
| Dental anesthesia | D000766 | — | — | — | — | — | 1 | 6 | 7 |
| Dental implants | D015921 | — | — | — | — | — | 1 | 5 | 6 |
| Periapical periodontitis | D010485 | EFO_1001391 | K04.5 | — | 3 | — | 1 | 2 | 6 |
| Anesthesia | D000758 | — | — | — | 1 | — | 1 | 4 | 6 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | — | — | 1 | 5 | 6 |
Show 21 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dental caries | D003731 | EFO_0003819 | K02 | — | 3 | 1 | — | 4 | 8 |
| Spinal anesthesia | D000775 | — | — | — | — | 2 | — | — | 2 |
| Wounds and injuries | D014947 | — | T14.8 | — | 1 | 1 | — | 1 | 2 |
| Dental pulp exposure | D003789 | EFO_1001782 | — | — | 1 | 1 | — | — | 1 |
| Stomatognathic diseases | D009057 | — | K08.9 | — | — | 1 | — | — | 1 |
| Child behavior | D002652 | — | — | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dental enamel hypoplasia | D003744 | EFO_1001304 | — | 2 | 2 | — | — | 2 | 4 |
| Molar hypomineralization | D000094604 | — | — | 2 | 2 | — | — | 2 | 4 |
| Postoperative complications | D011183 | — | — | 1 | 1 | — | — | 1 | 2 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Agnosia | D000377 | EFO_0007136 | F88 | 1 | — | — | — | 5 | 6 |
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | 1 | 2 |
| Atrophy | D001284 | — | — | 1 | — | — | — | 1 | 2 |
| Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | — | 1 |
| Bone regeneration | D001861 | — | — | 1 | — | — | — | — | 1 |
| Mandibular nerve injuries | D000080902 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dental anxiety | D016854 | — | — | — | — | — | — | 10 | 10 |
| Alveolar bone loss | D016301 | — | — | — | — | — | — | 4 | 4 |
| Wound healing | D014945 | GO_0042060 | — | — | — | — | — | 4 | 4 |
| Peri-implantitis | D057873 | EFO_1001390 | — | — | — | — | — | 4 | 4 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 4 | 4 |
| Gingival recession | D005889 | — | K06.0 | — | — | — | — | 3 | 3 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 3 | 3 |
| Edentulous mouth | D009066 | — | — | — | — | — | — | 3 | 3 |
| Tooth diseases | D014076 | — | — | — | — | — | — | 3 | 3 |
| Analgesia | D000698 | — | — | — | — | — | — | 2 | 2 |
Show 49 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Articaine |
| INN | articaine |
| Description | 4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic acid methyl ester is a thiophenecarboxylic acid. |
| Classification | Small molecule |
| Drug class | local anesthetics |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC |
Identifiers
| PDB | — |
| CAS-ID | 23964-58-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1093 |
| ChEBI ID | — |
| PubChem CID | 32170 |
| DrugBank | DB09009 |
| UNII ID | D3SQ406G9X (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2,846 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,007 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use